Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

IRMD holding history

Iradimed Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IRMD overviewAll 13F holders of IRMDFull Q2 2026 holdings

Shares (Q2 2026)
10,662
Value
$1.02M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IRMD by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,662$1.02M<0.1%−3,980−27.2%ReducedHolders
Q1 202614,642$1.41M<0.1%−2,326−13.7%ReducedHolders
Q4 202516,968$1.65M<0.1%−8,465−33.3%ReducedHolders
Q3 202525,433$1.81M<0.1%+20,242+389.9%AddedHolders
Q2 20255,191$310.4K<0.1%−3,921−43.0%ReducedHolders
Q1 20259,112$478.2K<0.1%−10,688−54.0%ReducedHolders
Q4 202419,800$1.09M<0.1%+13,812+230.7%AddedHolders
Q3 20245,988$301.1K<0.1%+1,260+26.6%AddedHolders
Q2 20244,728$207.7K<0.1%−3,747−44.2%ReducedHolders
Q1 20248,475$372.8K<0.1%+1,237+17.1%AddedHolders
Q4 20237,238$343.6K<0.1%+4,349+150.5%AddedHolders
Q3 20232,889$128.2K<0.1%−12,149−80.8%ReducedHolders
Q2 202315,038$717.9K<0.1%+7,370+96.1%AddedHolders
Q1 20237,668$301.7K<0.1%−2,248−22.7%ReducedHolders
Q4 20229,916$280.5K<0.1%+9,125+1,153.6%AddedHolders
Q3 2022791$24.0K<0.1%−602−43.2%ReducedHolders
Q2 20221,393$47.0K<0.1%−1,229−46.9%ReducedHolders
Q1 20222,622$117.0K<0.1%+174+7.1%AddedHolders
Q4 20212,448$113.0K<0.1%+2,448NewHolders
Q3 20210$00.0%−3−100.0%Sold outHolders
Q2 20213$00.0%−1,677−99.8%ReducedHolders
Q1 20211,680$43.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.